CRM Salesforce Inc

$CRM On May 18th BofA downgraded $CRM to sell. Stock price was $172. It has rallied 32.6% since. Now they double upgrade the stock back to buy with the stock at $229 All one can do is laugh...

$CRM 236 support here, buying opportunity...but the other good opportunity is $NFLX at 52 week low....both will make a come back within 6 months

$CRM NOV20 250C · still actionable Zone: $240.75 to $244.15 Invalidation: close under $236.90 Objectives: $251.94, then $269.11 The math: up 3.9% to the first objective and 11.0% to the second, against 2.3% risk on the invalidation, about 4.8 to 1 to the second Dear friend, think of this swing setup like a shop on a busy street that took a quiet dip last week and has customers walking back in today. Salesforce closed at 242 dollars and 45 cents after buyers held the 236 dollars and 90 cents low, and price sits above its 50 day average near 230 dollars, which means the floor underneath is not the story here, the recovery toward the old highs is. Earnings on December 2 sit after this contract ends, so the idea works on price alone, with room first toward the October 16 high and then toward the yearly high if buyers keep pressing. P.S. Watch the 243 dollars and 1 cent high from today, because a close above it would say buyers are ready to test 251 dollars and 94 cents next.

$CRM NOV20 250C · still actionable Zone: $239.90 to $243.30 Invalidation: close under $237 Objectives: $256, then $270 The math: up 6.0% to the first objective and 11.8% to the second, against 1.9% risk on the invalidation, better than 6 to 1 to the second Think of this as a big ship that took a knock on a headline and kept floating near the same line all week, which tells you buyers are still standing there. Salesforce just agreed to buy Braze, and that gives the story a clear reason for money to keep looking here while the price holds above that low near 237. This is a swing setup, plain and simple, a hold of support with room back toward the old highs if the zone stays firm. What that means for you is the wrong point is easy to see, and the room above is much larger than the room below. P.S. Watch how it acts on the first test of 244, the high from the last session, because a close above there opens the road to the first objective.

$CRM Business software maker Salesforce (CRM.N), opens new tab said on Thursday it would buy defense technology company ​Rune Technologies to expand its Missionforce ‌business, which serves the US military and government agencies.

$CRM working on a theory..most AI tech is dumping currently. Lot of debt out there without proven revenue. Salesforce is already presently making money from AI with proven results in their balance sheet and does not have the big capex debt of other said AI tech companies. Market seems to be rewarding that. Same thing with $NOW $META $ORCL $GOOG

$CRM asking for a friend MSFT already test that double top ATH Will this head there ?? lol

$CRM Salesforce Shares up 3.7% Premarket After BofA Global Research Raises to Buy From Underperform

$CRM NOV20 250C · still actionable Zone: $240.73 to $244.13 Invalidation: close under $235.60 Objectives: $257, then $269 The math: up 6.0% to the first objective and 11.0% to the second, against 2.8% risk on the invalidation, better than 3 to 1 to the second Dear friend, picture a strong shop that just paid a big price for a new tool and got scolded for it all morning. Salesforce said it will buy Braze for 47.50 dollars a share in cash, the stock slid to 235.60 dollars, and then it closed back at 242.43 dollars, which means buyers stepped in at the low and would not let the scolding turn into a slide. This is a swing setup, plain and simple: hold above that low and there is room first toward 257 dollars and then toward the high near 269 dollars from late last year. P.S. Watch 244.14 dollars first. That was the high today, and a close above it would show buyers pressing, not just defending.

$CRM Double bottom off the 50d, confimred thru 240. Has reclaimed HVC candle low. Out of a 3wt on the weekly. Monthly MacD cross

$CRM PE is 20. PSales is 4. Revenue Growth rate is over 10%. EPS growth is over 20%. Ignore the idiots and the fear because you're buying a good company with very good numbers.

$CRM 15 minute and 30 minute MACD pointing up could start trending towards center line. From there we will make a decision

$CRM $UNH salesforce putting pressure on Dow. crm should recover once the market opens though. $SPY crm buying braze an AI company

$CRM - $196 billion market cap $ZETA - $8 billion market cap 👀🚨 introducing AthenaOS will be the difference maker on filling the gap. Watch!

$CRM can we please finish the day at 235? Double upgrade should have kept this way over 240

$CRM Adjusted Operating income per share was 2.84 last quater. $MU was Adjsuted Operated income per share was 38.85. $MU made 13x the income yet 5x the price. $MU is in the news because everything they can make is sold out and getting more expensive every quarter. $CRM is in the news because it sold bonds to buy back shares to artificially boost the stock price. LOL clown world. there are so many cheap and better alternatives to $CRM

$CRM I think these 2 posts perfectly sum up so many on ST who trade when they really shouldn't be and why so many people think of this profession as gambling Dont know why a stock is up or down, doesnt get any data or info & wont do any due dilly but, Buying anyway Cant get more ridiculous then that $CRM $META $AAPL $QQQ

$CRM Markets goping to start appreciating asset light, margin heavy companies at low p/e when the AI bubble nwinds in earnest. Consistently growing high margin software companies like CRM could be seen as a safe haven in a market where all the biggest tech companies are now sitting on piles of debt and depreciating assets.

$CRM nibbled more at 239s I think Anthropic agents will need saleforce platform to operate for enterprise AI agents

Four acquisitions announced before the open today: 1. Salesforce buys Braze, $5.7B 2. Silgan and Trivium combine, $3.4B 3. Tradeweb buys Trumid, $1.97B 4. Merck buys Silence Therapeutics, $1.3B $12.4 billion before the open! $CRM $SLGN $TW $MRK